This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gray, D. R. Articles by Smith, G. J. Search for Related Content PubMed PubMed Citation Articles by Gray, D. R. Articles by Smith, G. J.

Short-Term Human Prostate Primary Xenografts

An in Vivo Model of Human Prostate Cancer Vasculature and Angiogenesis

¹ Department of Pathology and Laboratory Medicine and ² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina

Transgenic spontaneously occurring and transplantable xenograft models of adenocarcinoma of the prostate (CaP) are established tools for the study of CaP progression and metastasis. However, no animal model of CaP has been characterized that recapitulates the response of the human prostate vascular compartment to the evolving tumor microenvironment during CaP progression. We report that primary xenografts of human CaP and of noninvolved areas of the human prostate peripheral zone transplanted to athymic nude mice provide a unique model of human angiogenesis occurring in an intact human prostate tissue microenvironment. Angiogenesis in human kidney primary xenografts established from human renal cell carcinoma and noninvolved kidney tissue, a highly vascular organ and cancer, was compared with angiogenesis in xenografts from the relatively less vascularized prostate. Immunohistochemical identification of the human versus mouse host origin of the endothelial cells and of human endothelial cell proliferation in the human prostate and human kidney xenografts demonstrated that: (a) the majority of the vessels in primary xenografts of benign and malignant tissue of both organs were lined with human endothelial cells through the 30-day study period; (b) the mean vessel density was increased in both the CaP and benign prostate xenografts relative to the initial tissue, whereas there was no significant difference in mean vessel density in the renal cell carcinoma and benign kidney xenografts compared with the initial tissue; and (c) the number of vessels with proliferating endothelial cells in primary xenografts of CaP and benign prostate increased compared with their respective initial tissue specimens, whereas the number of vessels with proliferating endothelial cells decreased in the benign kidney xenografts. Short-term primary human prostate xenografts, therefore, represent a valuable in vivo model for the study of human angiogenesis within a human tissue microenvironment and for comparison of angiogenesis in CaP versus benign prostate.

This article has been cited by other articles:

				V. C. Daniel, L. Marchionni, J. S. Hierman, J. T. Rhodes, W. L. Devereux, C. M. Rudin, R. Yung, G. Parmigiani, M. Dorsch, C. D. Peacock, et al. A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro Cancer Res., April 15, 2009; 69(8): 3364 - 3373. [Abstract] [Full Text] [PDF]

				H. Hu, Y. Ran, Y. Zhang, Z. Zhou, S. J. Harris, L. Yu, L. Sun, J. Pan, J. Liu, J. Lou, et al. Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target Mol. Cell. Proteomics, April 1, 2009; 8(4): 816 - 826. [Abstract] [Full Text] [PDF]

				A. Godoy, A. Watts, P. Sotomayor, V. P. Montecinos, W. J. Huss, S. A. Onate, and G. J. Smith Androgen Receptor Is Causally Involved in the Homeostasis of the Human Prostate Endothelial Cell Endocrinology, June 1, 2008; 149(6): 2959 - 2969. [Abstract] [Full Text] [PDF]

				D. G. Duda, D. Fukumura, L. L. Munn, M. F. Booth, E. B. Brown, P. Huang, B. Seed, and R. K. Jain Differential Transplantability of Tumor-Associated Stromal Cells Cancer Res., September 1, 2004; 64(17): 5920 - 5924. [Abstract] [Full Text] [PDF]